Occupational exposures and lung cancer risk among Minnesota taconite mining workers

Objective To examine the association between employment duration, elongate mineral particle (EMP) exposure, silica exposure and the risk of lung cancer in the taconite mining industry. Methods We conducted a nested case–control study of lung cancer within a cohort of Minnesota taconite iron mining workers employed by any of the mining companies in operation in 1983. Lung cancer cases were identified by vital records and cancer registry data through 2010. Two age-matched controls were selected from risk sets of cohort members alive and lung cancer free at the time of case diagnosis. Calendar time-specific exposure estimates were made for every job and were used to estimate workers’ cumulative exposures. ORs and 95% CIs were estimated using conditional logistic regression. We evaluated total lung cancer risk and risk of histological subtype by total work duration and by cumulative EMP, and silica exposure by quartile of the exposure distribution. Results A total of 1706 cases and 3381 controls were included in the analysis. After adjusting for work in haematite mining, asbestos exposure and sex, the OR for total duration of employment was 0.99 (95% CI 0.96 to 1.01). The ORs for quartile 4 versus 1 of EMP and silica exposure were 0.82 (95% CI 0.57 to 1.19) and 0.97 (95% CI 0.70 to 1.35), respectively. The risk of each histological subtype of lung cancer did not change with increasing exposure. Conclusions This study suggests that the estimated taconite mining exposures do not increase the risk of developing lung cancer.

[1]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[2]  B. Alexander,et al.  Mortality experience among Minnesota taconite mining industry workers , 2014, Occupational and Environmental Medicine.

[3]  B. Alexander,et al.  Comprehensive assessment of exposures to elongate mineral particles in the taconite mining industry. , 2013, The Annals of occupational hygiene.

[4]  J. Gamble,et al.  Letter to the editor on commentary: malignant mesothelioma incidence among talc miners and millers in New York state by M M Finkelstein. , 2013, American journal of industrial medicine.

[5]  M. Finkelstein Malignant mesothelioma incidence among talc miners and millers in New York State. , 2012, American journal of industrial medicine.

[6]  Benjamin M. Robinson,et al.  Malignant pleural mesothelioma: an epidemiological perspective. , 2012, Annals of cardiothoracic surgery.

[7]  K. Straif,et al.  Quantitative relationship between silica exposure and lung cancer mortality in German uranium miners, 1946–2003 , 2012, British Journal of Cancer.

[8]  Douglas Trout,et al.  Asbestos fibers and other elongate mineral particles; state of the science and roadmap for research , 2011 .

[9]  Michael E Berndt,et al.  The origins of public concern with taconite and human health: Reserve Mining and the asbestos case. , 2008, Regulatory toxicology and pharmacology : RTP.

[10]  Peter L McSwiggen,et al.  Overview of the mineralogy of the Biwabik Iron Formation, Mesabi Iron Range, northern Minnesota. , 2008, Regulatory toxicology and pharmacology : RTP.

[11]  Graham W Gibbs,et al.  An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments. , 2008, Regulatory toxicology and pharmacology : RTP.

[12]  B. Mossman,et al.  Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays. , 2008, Regulatory toxicology and pharmacology : RTP.

[13]  J. D. Miller,et al.  Geology of the Biwabik Iron Formation and Duluth Complex. , 2008, Regulatory toxicology and pharmacology : RTP.

[14]  E. Mcconnell,et al.  Risk assessment due to environmental exposures to fibrous particulates associated with taconite ore. , 2008, Regulatory toxicology and pharmacology : RTP.

[15]  J. Robins,et al.  Causal Directed Acyclic Graphs and the Direction of Unmeasured Confounding Bias , 2008, Epidemiology.

[16]  Y. Honda,et al.  Mortality among workers at a talc mining and milling facility. , 2002, The Annals of occupational hygiene.

[17]  A. D. McDonald,et al.  The epidemiology of mesothelioma in historical context. , 1996, The European respiratory journal.

[18]  M. Hobbs,et al.  Exposure to crocidolite and the incidence of different histological types of lung cancer. , 1996, Occupational and environmental medicine.

[19]  K. Steenland,et al.  Mortality study of gold miners exposed to silica and nonasbestiform amphibole minerals: an update with 14 more years of follow-up. , 1995, American journal of industrial medicine.

[20]  B. Korsgaard,et al.  Incidence of lung cancer by histological type among asbestos cement workers in Denmark. , 1993, British journal of industrial medicine.

[21]  O. Wong,et al.  An updated study of taconite miners and millers exposed to silica and non-asbestiform amphiboles. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[22]  O. Wong,et al.  Mortality of Workers in Two Minnesota Taconite Mining and Milling Operations , 1988, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[23]  R. G. Cornell,et al.  Mortality of Reserve Mining Company employees in relation to taconite dust exposure. , 1983, American journal of epidemiology.

[24]  F. Moatamed,et al.  Asbestos-related diseases. , 1981, Clinics in chest medicine.

[25]  A. Rohl,et al.  THE CONTAMINATION OF LAKE SUPERIOR WITH AMPHIBOLE GANGUE MINERALS * , 1979, Annals of the New York Academy of Sciences.

[26]  A. D. McDonald,et al.  Mortality after long exposure to cummingtonite-grunerite. , 1978, The American review of respiratory disease.

[27]  J. Dement,et al.  MORTALITY PATTERNS AMONG HARD ROCK GOLD MINERS EXPOSED TO AN ASBESTIFORM MINERAL * , 1976, Annals of the New York Academy of Sciences.

[28]  이수정 해외산업간호정보 - 미국 산업안전보건연구원(National Institute for Occupational Safety and Health) 소개 , 2009 .

[29]  J Espinosa Arranz,et al.  [Malignant mesothelioma]. , 1994, Medicina clinica.